Astera Labs, Inc. ALAB
Composite 64/100; the shares have moved about 102% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 7/100 — a strong mark against it.
Growth ranks 96/100 — a strong point in its favour. Balance-sheet strength ranks 96/100 — a strong point in its favour. Quality ranks 69/100 — a moderate point in its favour.
Valuation ranks 7/100 — a strong mark against it.
What the company does Astera Labs designs high-speed connectivity chips and software for AI and cloud infrastructure, serving hyperscalers and OEMs with PCIe/CXL retimers, smart cable modules, and the COSMOS management suite.
Key financials Astera posts gross margins of 76%, operating margins of 20%, and net margins of 27%. Revenue and EPS grew 93% and 144% year-over-year, respectively. ROE is 21%, ROA 10%, and ROCE 18%, with a debt/equity of 0.03 and current ratio of 11.3.
Stock health The stock shows strong momentum with 3m, 6m, and 12m gains of 52%, 78%, and 153%, but is down 40% from its 52-week high. Sideravia scores Quality 71, Growth 95, Strength 99, Valuation 4, and Momentum 78.
Price vs fair value The stock trades at a discount of 0.17% to the 12-month analyst target of 300.19. - Trading near target despite high valuation multiples (P/E 223, EV/EBITDA 235) (Analyst consensus) - Recent comparisons to peers (Intel, CoreWeave, Nebius) spark debate on relative attractiveness (Motley Fool) - Bullish momentum amid tech-led rebound, offsetting software sector weakness (Barrons.com) - Revenue growth of 115% cited as justification for premium despite valuation concerns (Simply Wall St) - Stock fell more than the market on 7/29, suggesting near-term volatility (Zacks)
Looking forward Forward P/E of 111 and PEG of 1.11 imply high expectations for continued growth, while FCF yield of 0.4% signals limited cash return to shareholders. Analysts’ 12-month target implies limited upside from current levels.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.